Search Browse Earnings

Evommune, Inc. — SlamSEC

Evommune, Inc.

NYSE:EVMN

Pharmaceutical Preparations·PALO ALTO, CA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$7.0M

FY 2025

Adj. EBITDA

-$69.5M

-993.0% margin

FY 2025

Net Income

-$66.8M

-954.4% margin

FY 2025

EPS (Diluted)

-$45.29

FY 2025

Stock Price

$24.48

-2.4%

2026-03-09

52W Range

$13.88 – $33.20

P/E Ratio

-0.5x

Market Cap

$881.7M

Cash

$16.3M

FY 2025

Total Debt

—

Net Cash

$16.3M

FY 2025

Enterprise Value

$865.5M

Debt / EBITDA

0.2x

FY 2025

EV / EBITDA

-12.5x

Employees

—